The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) is an international financing organization that supports disease prevention, treatment programs, and related research in high-burden regions.
GFATM-supported clinical studies often include implementation research, pragmatic trials, and program evaluations that generate evidence in real-world settings. Funding requirements can shape data reporting, safety oversight expectations, and governance structures for sponsored studies. Research may involve vulnerable populations, making informed consent quality, community engagement, and risk mitigation especially important. Well-run GFATM studies contribute to evidence-based public health impact and responsible global research conduct.